An inhaled mental health drug could appear on the market in the near future under a collaboration announced Wednesday by Biovail Corp. and Alexza Pharmaceuticals. Biovail subsidiary Biovail Labs International SRL ... Read More
U.S. solar-panel manufacturer SunPower has signed an agreement to acquire SunRay Renewable Energy and its existing solar projects for $277 million, both companies announced Thursday. The maker of high-efficiency solar panels ... Read More
Micron Technology announced late Tuesday that it was acquiring Numonyx Holdings in an all-stock deal worth about $1.27 billion, a move that may help it challenge Samsung and Toshiba. Numonyx, formed ... Read More
LaBarge Inc. has landed contracts valued at $1 million from London-based BAE Systems to make circuit card assemblies for missile warning systems. LaBarge Inc. has landed contracts valued at $1 million ... Read More
St. Louis biotech firm Divergence Inc. said Tuesday it received two Small Business Innovation Research grants totaling $500,000, along with renewed funding from the National Corn Growers Association, to support its ... Read More
Sisters of Mercy Health System networks took two of the top three spots in a recent rating of the nation’s top 100 most integrated health-care networks. In health analytics firm SDI’s ... Read More
German drug company Boehringer Ingelheim is in talks to make Japanese subsidiary SSP Co Ltd (4537.T) wholly-owned in a deal worth more than 30 billion yen ($335 million), the Nikkei newspaper ... Read More
Thin-film solar cells hold the promise of a cheap, renewable energy source that could make fossil fuels obsolete, but thus far the cells’ reliance on rare elements and expensive vacuum deposition ... Read More
The Missouri Department of Economic Development (DED) announced today that a Springfield location has been designated as the state’s second Certified Site. Chosen by DED’s Certified Site team, the site will ... Read More
AstraZeneca won approval Monday to promote its cholesterol fighting drug Crestor for preventing heart disease in a vast new market of people with healthy cholesterol but other heart risks. Crestor won ... Read More